TiumBio Co., Ltd. (KOSDAQ:321550)
6,740.00
-50.00 (-0.74%)
At close: Mar 9, 2026
TiumBio Revenue
TiumBio had revenue of 3.12B KRW in the quarter ending September 30, 2025, with 175.77% growth. This brings the company's revenue in the last twelve months to 9.32B, up 21.54% year-over-year. In the year 2024, TiumBio had annual revenue of 6.79B with 38.65% growth.
Revenue (ttm)
9.32B
Revenue Growth
+21.54%
P/S Ratio
21.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
195.99B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Prestige Biologics | 19.24B |
| Ensol Biosciences | 537.46M |
| ISU Abxis | 66.39B |
| Kangstem Biotech | 12.77B |
| QuadMedicine | 13.11B |
| Genome & Company | 25.95B |
| ABION | 1.03B |
| Bio Solution | 8.27B |